Berlin — Raue is expanding its corporate and transactional team with the addition of Dr. Nadine Hartung (photo © Raue) as Equity Partner on March 1, 2023. Dr. Nadine Hartung specializes in corporate law and M&A advice in the healthcare sector and was previously a partner at McDermott Will & Emery in Munich.
Dr. Nadine Hartung advises national and international investors as well as healthcare providers on corporate law, M&A transactions, contract drafting and corporate governance and compliance issues. Her clients include private equity and venture capital funds, medical care centers (MVZ), operators of hospitals and nursing homes, as well as pharmaceutical companies and medical device manufacturers. It is recommended by Legal 500, Best Lawyers and Handelsblatt.
Dr. Nadine Hartung studied and received her doctorate in Marburg. From 2010 to 2016, she worked at Hengeler Mueller in Berlin and Frankfurt am Main before joining McDermott Will & Emery LLP in 2016. In 2013/2014, she spent a secondment in the M&A team of Cravath, Swaine & Moore in New York.
Dr. Hartung explains the reasons for her move to Raue: “Raue offers numerous synergies to my advisory practice, especially in corporate law and VC advisory as well as in healthcare law and digital economy. I look forward to working with my colleagues at Raue to further expand transactional advice focused on the healthcare sector in particular.”
Raue Managing Partner Dr. Wolfram Hertel: “We are very pleased that Dr. Hartung has joined us. With her, we have found an experienced partner personality who has developed an industry-focused advisory offering — this fits perfectly with our own strategic approach. We continue to focus on growth in advising regulated industries and technologies.”
Prof. Dr. Andreas Nelle, Partner at Raue in the Corporate and M&A practice, says of Dr. Hartung’s arrival: “Dr. Hartung is an excellent addition to our private equity / venture capital advisory practice. With her, we will further increase our expertise in advising transactions, in particular also for national and international investors in the healthcare industry.”
Dr. Katharina Wodarz, partner at Raue in the healthcare sector adds: “Dr. Nadine Hartung is an almost ideal addition for us. She has known the healthcare sector for many years and is familiar with its complex regulation. This allows for seamless collaboration with our strong regulatory team when advising on new business models and transactions.”
With the addition of Dr. Nadine Hartung, Raue’s Corporate/M&A, PE/VC practice comprises a total of 14 professionals (six equity partners, one counsel, one senior associate, one of counsel and five associates).
About RAUE
Raue is an internationally active law firm based in Berlin. She provides comprehensive advice to national and international companies and public entities on investment projects, transactions, regulatory issues and contentious disputes. www.raue.com.